Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions
Hosted By : Andrea CharlesDecember 13, 2011
Rate this Podcast:
(4.3 Stars | 4 Votes)
About this Podcast...
In this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA speaks to Andrea Charles from Pharma IQ, about the Saudi FDA pharmacovigilance system and what new guidelines he predicts will be areas for discussion amongst pharma/bio companies in 2012. Dr. Nasser Al-Qahtani shares his insights on the impact of social media on the pharmacovigilance system and the initiatives the Saudi FDA are planning to implement to establish the importance of pharmacovigilance for the safety of the patient.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Rate this Podcast:
(4.3 Stars | 4 Votes)
Events of Interest
-
Adverse Event Reporting Online Training Course 2011
August 3, 2011
Register Now -
Global Formulation and Drug Delivery Summit 2012
Park Hotel Amsterdam, Netherlands
April 16- 18, 2012 -
Cold Chain Saudi Summit
Radisson Blu, Riyadh, Saudi Arabia
May 13- 16, 2012 -
4th Clinical Trials Supply & Logistics Summit
San Francisco, CA
June 25- 27, 2012






Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!